Literature DB >> 19578108

Glomerular expression of toll-like receptor-9 in lupus nephritis but not in normal kidneys: implications for the amplification of the inflammatory response.

E D Papadimitraki1, M Tzardi, G Bertsias, E Sotsiou, Dimitrios T Boumpas.   

Abstract

Toll-like receptors recognising self-derived nucleic acids may participate in the pathogenesis of autoimmune diseases. Following the description of an enhanced population of toll-like receptor-9 (TLR-9) expressing auto-antibody producing B lymphocytes in active lupus, we explored the expression of TLR-9 in the renal tissue of patients with lupus. TLR-9 expression was studied in the kidneys of 12 lupus and 10 control samples from macroscopically unaffected areas of patients with renal adenocarcinoma by immunohistochemistry. A semiquantitative score was assigned separately for tubular, interstitial and glomerular expression. TLR-9 was expressed in the renal tubules and interstitial tissue in both patients with lupus and controls. Six of 12 patients with lupus with proliferative or membranous nephritis - as compared to none of the controls - exhibited both tubulointerstitial and glomerular TLR-9 expression. Biopsies with glomerular TLR-9 expression had a higher activity index (mean +/- SD, 6.3 +/- 3.5 in the presence of TLR-9 glomerular expression as compared to 1.3 +/- 1.8 in its absence, P = 0.015, t-test). This study documents for the first time the up-regulation of TLR-9 within the glomerulus of patients with lupus nephritis. Activation of TLR-9 expressing glomerular cells by endogenous nucleic acids (nucleosomes) may amplify the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19578108     DOI: 10.1177/0961203309103054

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  26 in total

Review 1.  Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.

Authors:  P Lenert
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

Review 2.  Toll-like receptors and lupus nephritis.

Authors:  Fabrizio Conti; Francesca Romana Spinelli; Cristiano Alessandri; Guido Valesini
Journal:  Clin Rev Allergy Immunol       Date:  2011-06       Impact factor: 8.667

Review 3.  The role of Toll-like receptors in renal diseases.

Authors:  Anna Gluba; Maciej Banach; Simon Hannam; Dimitri P Mikhailidis; Agata Sakowicz; Jacek Rysz
Journal:  Nat Rev Nephrol       Date:  2010-02-23       Impact factor: 28.314

4.  FcγRIIIa Signaling Modulates Endosomal TLR Responses in Human CD4+ T Cells.

Authors:  Anil K Chauhan
Journal:  J Immunol       Date:  2017-05-12       Impact factor: 5.422

Review 5.  Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.

Authors:  Chandra Mohan; Chaim Putterman
Journal:  Nat Rev Nephrol       Date:  2015-03-31       Impact factor: 28.314

Review 6.  Ischemia as a factor affecting innate immune responses in kidney transplantation.

Authors:  Sashi G Kasimsetty; Dianne B McKay
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-01       Impact factor: 2.894

Review 7.  Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations.

Authors:  Kristen Renee McSweeney; Laura Kate Gadanec; Tawar Qaradakhi; Benazir Ashiana Ali; Anthony Zulli; Vasso Apostolopoulos
Journal:  Cancers (Basel)       Date:  2021-03-29       Impact factor: 6.639

Review 8.  Innate immunity in donor procurement.

Authors:  Kitty P Cheung; Sashi G Kasimsetty; Dianne B McKay
Journal:  Curr Opin Organ Transplant       Date:  2013-04       Impact factor: 2.640

Review 9.  Pattern recognition receptors and the inflammasome in kidney disease.

Authors:  Jaklien C Leemans; Lotte Kors; Hans-Joachim Anders; Sandrine Florquin
Journal:  Nat Rev Nephrol       Date:  2014-06-03       Impact factor: 28.314

10.  Evolution of chronic kidney disease in patients with systemic lupus erythematosus over a long-period follow-up: a single-center inception cohort study.

Authors:  Elisheva Pokroy-Shapira; Ilana Gelernter; Yair Molad
Journal:  Clin Rheumatol       Date:  2014-02-19       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.